The Claim
In hypercholesterolemic adults receiving statin therapy, repeated subcutaneous administration of AMG 145 at doses of 35 mg or higher per week results in sustained reductions in low-density lipoprotein cholesterol (LDL-C) of up to 81%, with consistent effects observed across dosing intervals, supporting the durability of pharmacological activity and the feasibility of weekly or biweekly dosing regimens.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A drug called AMG 145, when given as a weekly shot at 35 mg or more, can cut bad cholesterol by up to 81% in people already on cholesterol meds, and the effect lasts through the week—so it might work well even if given every other week.
See the scientific wording
Repeated subcutaneous dosing of AMG 145 at 35 mg weekly or higher causes sustained reductions in LDL-C of up to 81% in hypercholesterolemic adults on statin therapy, with effects maintained across dosing intervals, indicating durable pharmacological activity and support for weekly or biweekly administration regimens.
What the research says
1 studyThe study tested the same medicine, dose, and schedule claimed, and found it worked just as well as stated, lowering bad cholesterol by up to 81% in people on statins.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.